Screening of Prognostic Markers for Hepatocellular Carcinoma Patients Based on Multichip Combined Analysis

Figure 2

GO and KEGG pathway analyses of DEmRNAs in HCC: (a, b) GO and KEGG enrichment analyses of DEGs.

(a)

(b)